MedTrace Logo

Single Dose Study of GSK1440115 in Patients With Asthma

NCT01424280 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-12-02

No results posted yet for this study

Summary

The purpose of this study is to assess bronchodilator effect after single dose administration of GSK1440115 in a population of mild to moderate asthmatic patients.

Conditions

Interventions

DRUG

1440115

Single dose of either 750 mg or 500 mg administered as 250 mg tablets.

DRUG

Placebo

Single dose of matching placebo tablets

Sponsors & Collaborators

  • Accenture

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-11-30

Countries

  • Australia

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01424280 on ClinicalTrials.gov